Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Transmembrane protein 11, mitochondrial (TMEM11) is an integral protein primarily localized to the outer mitochondrial membrane, where it plays a critical role in maintaining mitochondrial architecture and regulating mitochondrial dynamics, particularly the balance between mitochondrial fission and fusion[2][3]. TMEM11 interacts with proteins of the MICOS complex (mitochondrial contact site and cristae organizing system) and mitophagy regulators BNIP3 and BNIP3L, thereby influencing the spatial activation of mitophagy, especially under stress conditions such as hypoxia[2]. Disruption or depletion of TMEM11 leads to loss of mitochondrial tubular morphology, enlargement or fragmentation of mitochondria, impaired cristae structure, and can negatively impact cellular and organismal physiology, including neuronal function and cardiomyocyte proliferation in model organisms[1][2][3]. While TMEM11 is critical for mitochondrial integrity, it is not currently considered a direct therapeutic target (such as an enzyme or receptor) and no interacting drugs or established biomarker applications have been identified in the literature as of the current date[2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Transmembrane protein 11, mitochondrial (TMEM11).